Literature DB >> 3263436

Active suppression of host-vs graft reaction in pregnant mice. IX. Soluble suppressor activity obtained from allopregnant mouse decidua that blocks the cytolytic effector response to IL-2 is related to transforming growth factor-beta.

D A Clark1, M Falbo, R B Rowley, D Banwatt, J Stedronska-Clark.   

Abstract

Non-Ts cells in murine allopregnancy decidua release potent immunosuppressor factors in vitro that block the action of IL-2. Previous studies have shown that both primary and secondary CTL responses are inhibited as well as the generation of Il-2 activated killer cells. In this paper we show that the suppressor factor(s) can arrest ongoing IL-2 dependent CTL responses but does not block binding of anti-IL-2R antibody or radiolabeled IL-2 to the IL-2R. The suppressive activity is associated with molecules that adhere to hydroxylapatite and con A-agarose but do not bind to activated charcoal or partition as lipids. HPLC TSK 3000 separation showed a major peak of suppressive activity at 60 to 100 kDa, with additional activity at 300 kDa, and at less than 1000. Under acid conditions, suppressive activity resolved as a major peak at 13 kDa with some residual activity at 65 kDa and at less than or equal to 1000. A specific rabbit IgG antibody to transforming growth factor-beta neutralized suppressor activity in unseparated supernatant and in the 13-kDa fraction whereas neutralizing antibodies to progesterone or PGE-2 did not affect suppression but could neutralize their respective ligands. Inasmuch as transforming growth factor-beta has a 25 kDa Mr, the 13-kDa decidua-associated suppressor factor would appear to represent a related but distinct regulatory molecule that associates with a variety of carrier molecules.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3263436

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Tumor-derived cytokines induce bone marrow suppressor cells that mediate immunosuppression through transforming growth factor beta.

Authors:  M R Young; M A Wright; M Coogan; M E Young; J Bagash
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

2.  Macrophage functions are regulated by murine decidual and tumor extracellular matrices.

Authors:  D B McKay; M A Vazquez; R W Redline; C Y Lu
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

3.  Human milk contains proteins that stimulate and suppress T lymphocyte proliferation.

Authors:  L Mincheva-Nilsson; M L Hammarström; P Juto; S Hammarström
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

4.  A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance.

Authors:  G Torre-Amione; R D Beauchamp; H Koeppen; B H Park; H Schreiber; H L Moses; D A Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

5.  Phenotypic and functional analysis of human CD3- decidual leucocyte clones.

Authors:  S E Christmas; J N Bulmer; A Meager; P M Johnson
Journal:  Immunology       Date:  1990-10       Impact factor: 7.397

6.  The immunomodulatory activity of human amniotic fluid can be correlated with transforming growth factor-beta 1 (TGF-beta 1) and beta 2 activity.

Authors:  A K Lang; R F Searle
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

7.  A transforming growth factor beta 2 (TGF-beta 2)-like immunosuppressive factor in amniotic fluid and localization of TGF-beta 2 mRNA in the pregnant uterus.

Authors:  D J Altman; S L Schneider; D A Thompson; H L Cheng; T B Tomasi
Journal:  J Exp Med       Date:  1990-11-01       Impact factor: 14.307

8.  A first or dominant immunization. II. Induced immunoglobulin carries transforming growth factor beta and suppresses cytolytic T cell responses to unrelated alloantigens.

Authors:  R M Stach; D A Rowley
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.